Latest Accounting News

Lithium Energy Limited has fast-tracked the sale of its remaining stake in the Solaroz Lithium Brine Project, securing US$21.7 million ahead of the planned timeline and strengthening its financial position.

Echo IQ has formally lodged its FDA 510(k) submission for EchoSolv HF, an AI-driven heart failure diagnostic software validated by Mayo Clinic data, aiming to tap into a $60 billion US market.

Korab Resources Limited reported a positive cash flow for the December 2024 quarter, maintaining a strong liquidity position with funding to support its exploration activities for over 17 quarters.

GreenX Metals has finalized its acquisition of a 90% stake in the Tannenberg Copper Project in Germany, expanding the licence area dramatically and aligning with growing European strategic priorities for critical minerals.

Macquarie Group Limited has announced an ordinary dividend of AUD 1.6883 per security for its perpetual capital notes, payable in March 2026. The distribution features a partially franked yield reflecting current market interest rates.

Australian Gold and Copper Ltd has released its inaugural Mineral Resource Estimate for the Achilles deposit in NSW's South Cobar region, revealing a substantial 38.5 million ounces silver-equivalent resource. This milestone underscores the company's growing footprint in precious and base metals exploration.

New Murchison Gold Limited has released its 2025 Mineral Resources and Ore Reserves update for the Crown Prince Gold Mine, reflecting initial mining depletion and confirming the project’s economic viability. The company is now focusing on underground potential and near-mine exploration.

Brazilian Rare Earths Limited’s scoping study confirms the Amargosa Bauxite-Gallium Project as a large-scale, capital-efficient direct-ship bauxite operation with robust economic returns and strategic market positioning.

Tissue Repair Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, denying any undisclosed information and confirming compliance with listing rules.

Anagenics Limited has announced a two-tranche placement to raise A$2.25 million, aiming to expand its health and wellness brands while retiring debt and supporting working capital.

Memphasys Limited has restructured its leadership by eliminating the CEO role to back a direct-selling global commercialisation strategy for its Felix™ System, anticipating imminent CE Mark approval to enter the European IVF market.

NH3 Clean Energy progresses its WAH2 Project through the FEED phase while forging a pivotal MoU with Japanese giant ITOCHU Corporation to develop clean ammonia bunkering in the Asia Pacific region by 2030.